Cargando…

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis

BACKGROUND: Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is unclear. The aim of this study is to determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moxey, Jayne, Huq, Molla, Proudman, Susanna, Sahhar, Joanne, Ngian, Gene-Siew, Walker, Jenny, Strickland, Gemma, Wilson, Michelle, Ross, Laura, Major, Gabor, Roddy, Janet, Stevens, Wendy, Nikpour, Mandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376778/ https://www.ncbi.nlm.nih.gov/pubmed/30764870 http://dx.doi.org/10.1186/s13075-019-1839-5

Ejemplares similares

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

Determinants of left ventricular structure, filling and long axis function in systemic sclerosis
por: Peverill, Roger E., et al.
Publicado: (2021)

Cardiovascular disease in systemic sclerosis - an emerging association?
por: Ngian, Gene-Siew, et al.
Publicado: (2011)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
por: Calderone, Alicia, et al.
Publicado: (2016)

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3
por: Zochling, Jane, et al.
Publicado: (2014)

Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis
por: Vincent, Fabien B, et al.
Publicado: (2018)

When Anti-Neutrophil Cytoplasmic Antibody Fails: A Case of Anti-Neutrophil Cytoplasmic Antibody Negative Granulomatosis With Polyangiitis
por: Gangireddy, Mounika, et al.
Publicado: (2020)

Interactions of cytoplasmic granules with microtubules in human neutrophils
Publicado: (1989)

Anti-Neutrophil Cytoplasmic Antibody in Behçet’s Disease
por: Duzgun, Nursen, et al.
Publicado: (2006)

Anti-Neutrophil Cytoplasmic Antibodies: To Care or Not to Care
por: Shahid, Sara, et al.
Publicado: (2021)

The mechanoelectrical response of the cytoplasmic membrane of Vibrio cholerae
por: Rowe, Ian, et al.
Publicado: (2013)

Neutrophil Extracellular Traps Contain Selected Antigens of Anti-Neutrophil Cytoplasmic Antibodies
por: Panda, Rachita, et al.
Publicado: (2017)

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission
por: Muto, Reiko, et al.
Publicado: (2020)

Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils
por: Chen, Su-Fang, et al.
Publicado: (2018)

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
por: Morgan, Matthew David, et al.
Publicado: (2017)

A novel type of cytoplasmic granule in bovine neutrophils
Publicado: (1983)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Hellmark, Thomas, et al.
Publicado: (2019)

Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro
por: Popat, Reena J, et al.
Publicado: (2019)

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sun, Xiao-Jing, et al.
Publicado: (2023)

Myeloperoxidase anti‐neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti‐neutrophil cytoplasmic antibody‐associated microscopic polyangiitis
por: Yoshida, Masaharu, et al.
Publicado: (2016)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Zhang, Naidan, et al.
Publicado: (2022)

47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bi84fmhjg7hf87v6mabgpuhknn